Literature DB >> 23169233

HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis.

Thomas G Hofmann1, Carolina Glas, Nadja Bitomsky.   

Abstract

In response to DNA-damage, cells have to decide between different cell fate programmes. Activation of the tumour suppressor HIPK2 specifies the DNA damage response (DDR) and tips the cell fate balance towards an apoptotic response. HIPK2 is activated by the checkpoint kinase ATM, and triggers apoptosis through regulatory phosphorylation of a set of cellular key molecules including the tumour suppressor p53 and the anti-apoptotic corepressor CtBP. Recent work has identified HIPK2 as a regulator of the ultimate step in cytokinesis: the abscission of the mother and daughter cells. Since proper cytokinesis is essential for genome stability and maintenance of correct ploidy, this finding sheds new light on the tumour suppressor function of HIPK2. Here we highlight the molecular mechanisms coordinating HIPK2 function and discuss its emerging role as a tumour suppressor.
Copyright © 2013 WILEY Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23169233     DOI: 10.1002/bies.201200060

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  37 in total

Review 1.  The DNA damage-induced cell death response: a roadmap to kill cancer cells.

Authors:  Sonja Matt; Thomas G Hofmann
Journal:  Cell Mol Life Sci       Date:  2016-01-20       Impact factor: 9.261

2.  Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.

Authors:  Y Akaike; Y Kuwano; K Nishida; K Kurokawa; K Kajita; S Kano; K Masuda; K Rokutan
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

3.  Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.

Authors:  Yi Qin; Qiangsheng Hu; Shunrong Ji; Jin Xu; Weixing Dai; Wensheng Liu; Wenyan Xu; Qiqing Sun; Zheng Zhang; Quanxing Ni; Xianjun Yu; Bo Zhang; Xiaowu Xu
Journal:  Cell Prolif       Date:  2019-04-01       Impact factor: 6.831

Review 4.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.

Authors:  Yosef Shiloh; Yael Ziv
Journal:  Nat Rev Mol Cell Biol       Date:  2013-03-13       Impact factor: 94.444

5.  Loss of HIPK2 Protects Neurons from Mitochondrial Toxins by Regulating Parkin Protein Turnover.

Authors:  Jiasheng Zhang; Yulei Shang; Sherry Kamiya; Sarah J Kotowski; Ken Nakamura; Eric J Huang
Journal:  J Neurosci       Date:  2019-11-27       Impact factor: 6.167

6.  Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis.

Authors:  Kazunori Hashimoto; Yoshiaki Tsuji
Journal:  J Mol Biol       Date:  2016-11-21       Impact factor: 5.469

7.  The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.

Authors:  Christopher Agnew; Lijun Liu; Shu Liu; Wei Xu; Liang You; Wayland Yeung; Natarajan Kannan; David Jablons; Natalia Jura
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

8.  Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53.

Authors:  Min-Chi Yang; Ru-Wei Lin; Shih-Bo Huang; Shin-Yuan Huang; Wen-Jie Chen; Shiaw Wang; Yi-Ren Hong; Chihuei Wang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

9.  Identification of Hipk2 as an essential regulator of white fat development.

Authors:  Jonas Sjölund; Facundo G Pelorosso; David A Quigley; Reyno DelRosario; Allan Balmain
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-30       Impact factor: 11.205

10.  Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization.

Authors:  Tilman Polonio-Vallon; Joanna Kirkpatrick; Jeroen Krijgsveld; Thomas G Hofmann
Journal:  Cell Cycle       Date:  2013-10-25       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.